Inflation eases to 26-month low in Jan
India's headline inflation slowed to its lowest level in more than two years in January as food prices fell, increasing the pressure on the RBI to cut rates to battle the country's economic slowdown. Full Article
Reuters Showcase
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Wockhardt gets US nod for anti-ulcer syrup
U.S.'s next top dog
Two thousand dogs vie to be named "Best in Show" at New York's Westminster Kennel Club Dog Show. Slideshow
MUMBAI |
MUMBAI Feb 26 (Reuters) - Drug maker Wockhardt Ltd (WCKH.BO) said on Thursday it has secured U.S. Food and Drug Administration approval to sell an alcohol-free syrup of ranitidine hydrochloride, used to treat ulcers and hyper-acidity.
Ranitidine is the generic version of GlaxoSmithKline's (GSK.L) Zantac, the company said in a statement.
The U.S. market for the syrup is worth $51 million, the release said.
Wockhardt also said it has secured tentative approval for an alcholol-containing formulation of ranitidine. (Reporting by Bharghavi Nagaraju; editing by Rohini Ananthan)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters